(Q44004765)

28 November 2017

title

Viral dynamics in chronic hepatitis B patients during lamivudine therapy (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

2

1 reference

28 November 2017

4

Stefan Zeuzem

1 reference

28 November 2017

3

Hubert G M Niesters

1 reference

28 November 2017

Lonieke M M Wolters

1

1 reference

28 November 2017

Solko W Schalm

series ordinal

5

1 reference

28 November 2017

Robert A de Man

series ordinal

6

1 reference

28 November 2017

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

22

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

121-126

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Dynamics of hepatitis B virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Viral dynamics in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

7 January 2021

Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

7 January 2021

The intracellular phosphorylation of (-)-2'-deoxy-3'-thiacytidine (3TC) and the incorporation of 3TC 5'-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2002.01579.X

7 January 2021

10.1034/J.1600-0676.2002.01579.X

Identifiers

DOI

1 reference

28 November 2017

1 reference